Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Daily Reading

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (2)

Research Network

Common Treatments

  • Daily Reading1
  • Beverage Consumption1
  • Fundus Camera From Optomed1
  • Incident Dark Field Videomicroscope From Braedius1
  • Body Motion1

Active Sponsors

  • Lithuanian University of Health Sciences1
  • Jiannan Huang1
  • Research Council of Lithuania1

Top Investigators

Related Conditions

  • Sepsis1
  • Conjunctiva Disorder1

Activity Timeline